Enliven Therapeutics shares owned by Penserra Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Penserra Capital Management
from 13F filings
Historical chart of Penserra Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Penserra Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enliven Therapeutics by Penserra Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $845k | 17k | 50.72 |
More positions owned by Penserra Capital Management
View all positions for Penserra Capital Management